Customize cell culture reagents and drive sustainability in your development: Make media and buffers your competitive advantage
May
3
2023
On demand

Customize cell culture reagents and drive sustainability in your development: Make media and buffers your competitive advantage

Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Customize cell culture reagents and drive sustainability in your development: Make media and buffers your competitive advantage

Although cell therapies have shown great potential to treat life-threatening conditions such as cancer, they have yet to realize widespread adoption, due to some critical roadblocks, including financial and environmental costs.

The development process of cell therapies is extensive and requires a unique combination of expensive reagents and consumables, equipment, and experience to safely deliver a living drug to patients. Cell culture media and buffers customized and optimized to the growth characteristics of a specific cell type can positively impact critical aspects of development such as transduction efficiency, population doubling, yield, and maintenance of relevant phenotypes. This can greatly increase the therapeutic potency and expedite processes to accelerate time to market while reducing costs.

If custom media and buffers can streamline development significantly, why doesn’t everyone use custom designed media and buffers? Iterating media and reagents can be a time-consuming and costly process considering the amount of time needed for researching and sourcing components, and money spent on shipping, storage, quality control, validation of components, and waste from single-use plastics and minimal order volumes. Current scientific findings related to our environment paired with recent regulations and initiatives are telling. Future therapies and processes must ensure responsible environmental stewardship in addition to advanced curative potential. Nucleus Biologics and Stoic Bio’s ecosystem, including the award-winning NB-AIR™ and Krakatoa™, can simplify the process, reduce cost, and facilitate sustainable science.

In this webinar, joined by collaborators from the University of Pennsylvania and the Center for Breakthrough Medicines, we will cover how high quality GMP products such as custom media and buffers can improve processes, optimize critical quality attributes, and change the paradigm of cell culture science from research and development to bioreactor scale production.

  • How to expedite CAR-T process and what role custom media and reagent formulations play in this process
  • How a custom designed formulation (NB-ROC™) was designed to increase transduction efficiency up to 3-fold over competing formulations
  • How custom buffers can support efficient process development and improve product yields to support development
  • How Krakatoa media manufacturing system and the Nucleus Biologics media design ecosystem can support faster iteration with reduced environmental impact
Saba Ghassemi
Saba Ghassemi
Assistant Professor, Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine
Roddy O’Connor
Roddy O’Connor
Research Assistant Professor, Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine
Avi Nandi
Avi Nandi
Chief Technical Officer, Centre for Breakthrough Medicines
Kimberly Negrin
Kimberly Negrin
Business Unit Leader, Stoic Bio

SPEAKERS

Saba Ghassemi
Saba Ghassemi
Assistant Professor, Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine
Roddy O’Connor
Roddy O’Connor
Research Assistant Professor, Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine
Avi Nandi
Avi Nandi
Chief Technical Officer, Centre for Breakthrough Medicines
Kimberly Negrin
Kimberly Negrin
Business Unit Leader, Stoic Bio